Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage …

L Degenhardt, A Peacock, S Colledge… - The Lancet Global …, 2017 - thelancet.com
Background Sharing of equipment used for injecting drug use (IDU) is a substantial cause of
disease burden and a contributor to blood-borne virus transmission. We did a global …

A systematic review of injecting-related injury and disease among people who inject drugs

S Larney, A Peacock, BM Mathers, M Hickman… - Drug and alcohol …, 2017 - Elsevier
Background Non-viral injecting-related injuries and diseases (IRID), such as abscesses and
vascular damage, can result in significant morbidity and mortality if untreated. There has …

Undergraduate students' perspectives on digital competence and academic literacy in a Spanish University

F Guzmán-Simón, E García-Jiménez… - Computers in Human …, 2017 - Elsevier
Recent studies show that students' digital competence is part of a process of academic
literacy that requires the development of information and ICT literacies. This article attempts …

The impact of opioid agonist treatment on hospitalisations for injecting-related diseases among an opioid dependent population: A retrospective data linkage study

S Colledge-Frisby, N Jones, S Larney… - Drug and Alcohol …, 2022 - Elsevier
Background Injecting-related bacterial and fungal infections cause substantial illness and
disability among people who use illicit drugs. Opioid agonist treatment (OAT) reduces …

The effect of Montreal's supervised consumption sites on injection-related infections among people who inject drugs: An interrupted time series

J Lim, D Panagiotoglou - Plos one, 2024 - journals.plos.org
Background Between June and November 2017, four supervised consumption sites (SCS)
began operating in Montreal, Quebec. Earlier studies on SCS focused on examining their …

Establishing the Melbourne injecting drug user cohort study (MIX): rationale, methods, and baseline and twelve-month follow-up results

D Horyniak, P Higgs, R Jenkinson, L Degenhardt… - Harm Reduction …, 2013 - Springer
Background Cohort studies provide an excellent opportunity to monitor changes in
behaviour and disease transmission over time. In Australia, cohort studies of people who …

Differences in polysubstance use patterns and drug‐related outcomes between people who inject drugs receiving and not receiving opioid substitution therapies

KS Betts, G Chan, F McIlwraith, P Dietze… - …, 2016 - Wiley Online Library
Aims To test if polysubstance use profiles and drug‐related outcomes differ between those
receiving and not receiving opioid substitution therapies (OST) among people who inject …

Infective endocarditis in persons who use drugs: epidemiology, current management, and emerging treatments

A Schranz, JA Barocas - Infectious Disease Clinics, 2020 - id.theclinics.com
Serious bacterial and fungal infections such as infective endocarditis (IE) are among the
most common medical complications in persons who inject drugs (PWID). 1–3 IE once …

Behavioral characteristics and injection practices associated with skin and soft tissue infections among people who inject drugs: a community-based observational …

D Dahlman, A Håkansson, AH Kral… - Substance …, 2017 - journals.sagepub.com
Background: People who inject drugs (PWID) are at increased risk for bacterial skin and soft
tissue infections (SSTIs). Although SSTIs pose significant health risks, little is known about …

Economic evaluation of the effect of needle and syringe programs on skin, soft tissue, and vascular infections in people who inject drugs: a microsimulation modelling …

J Lim, WA Russell, M El-Sheikh, DL Buckeridge… - Harm Reduction …, 2024 - Springer
Background Needle and syringe programs (NSP) are effective harm-reduction strategies
against HIV and hepatitis C. Although skin, soft tissue, and vascular infections (SSTVI) are …